RGS5 and plasmacytoma: For example, overexpression of RGS1 inhibited CXCL12-mediated human plasmacytoma cell migration, and epigenetic inhibition of RGS2 has been associated with prostate cancer progression and overexpression of RGS5 on lung cancer cells (He et al., 2019).